Skip to main content

Find Clinical Trials

Home
Conditions
Acquired Pure Red Cell Aplasia

Clinical trial condition

Acquired Pure Red Cell Aplasia

Explore clinical trials studying Acquired Pure Red Cell Aplasia. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Acquired Pure Red Cell Aplasia trial results

Recruiting

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

NCT06412497

Conditions: Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Acquired amegakaryocytic thrombocytopenia, +11 more
Locations: University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Not Yet Recruiting

Linperlisib in the Treatment of aPRCA

NCT07031115

Conditions: Acquired Pure Red Cell Aplasia
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

NCT04423367

Conditions: Acquired Pure Red Cell Aplasia
Locations: Zhoukou Central Hospital Zhoukou, Henan, China

The Second Affilated Hospital of Shandong First Medical University Tai’an, Shandong, China

Regenerative Medicine Center Tianjin, China

View Trial Details